this is gonna get interesting GLGT
Areas of Focus: Cardiovascular and Infectious Diseases
AB (Wuhan) Biotech Co. Ltd. has developed two diagnostic kits or rapid test devices for cardiovascular diseases. The first product in our pipeline is a rapid test device for early diagnosis of acute myocardial infarction (AMI). Another is a test kit for the diagnosis of hypertriglyceridemia.
The best time frame to treat AMI is within the first three hours of it being identified. However, most AMI treatments are delayed due to the limitation of diagnostic tools, poor facilities at small community and rural hospitals in China, and patients' poor self-protective consciousness. Our product is designed to solve those problems.
It's specific, sensitive, simple and fast, with no requirement for any special equipment or apparatus. This provides AMI patients with an efficient, convenient and inexpensive tool to self-test at home, make quick checks in hospital emergency rooms, and enable fast screening tests in community or rural hospitals.
AB (Wuhan) Biotech Co. Ltd. can use a panel of antibodies/antigens to detect infectious diseases in patients instead of relying on just one single antibody/antigen. It can also develop several panels that cover different groups of infectious diseases. By using a properly selected panel in our test systems, we believe their reliability will be superior to a single pathogen/marker test.
News 
Market Data 
Discover 
